Clinical Cardiology Alert – December 1, 2004

December 1, 2004

• Late-Breaking Clinical Trials from the AHA Scientific Sessions

  Arguably the most important new trial to be reported in New Orleans was the African-American Heart Failure Trial; the use of a combination of isosorbide dinitrate and hydralazine in African-Americans with congestive heart failure.

  Read more about Late-Breaking Clinical Trials from the AHA Scientific Sessions - Clinical Cardiology Alert – December 1, 2004

• Clinical Briefs in Primary Care Supplement

  Read more about Clinical Briefs in Primary Care Supplement - Clinical Cardiology Alert – December 1, 2004

• Pharmacology Watch: ACE Inhibitors and Receptor Blockers: Which is Inferior?

  The first head-to-head comparison study of an ACE inhibitor and an angiotensin receptor blocker, to assess renoprotective effects in type 2 diabetes, has shown that the drugs are comparable in their benefit.

  Read more about Pharmacology Watch: ACE Inhibitors and Receptor Blockers: Which is Inferior? - Clinical Cardiology Alert – December 1, 2004